Geller Advisors LLC Sells 1,046 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Geller Advisors LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 29.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,528 shares of the medical equipment provider's stock after selling 1,046 shares during the quarter. Geller Advisors LLC's holdings in Intuitive Surgical were worth $1,242,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in ISRG. Hazlett Burt & Watson Inc. lifted its stake in shares of Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock valued at $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. raised its holdings in Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider's stock valued at $247,000 after acquiring an additional 20 shares in the last quarter. Ullmann Wealth Partners Group LLC lifted its position in shares of Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider's stock worth $653,000 after acquiring an additional 21 shares during the period. Meeder Advisory Services Inc. grew its holdings in shares of Intuitive Surgical by 0.3% during the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider's stock worth $3,629,000 after purchasing an additional 22 shares in the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC increased its position in shares of Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider's stock valued at $310,000 after purchasing an additional 23 shares during the period. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts recently commented on ISRG shares. Robert W. Baird raised their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. Leerink Partners upped their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Finally, Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a report on Thursday. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $541.33.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the business's stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company's stock, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 450 shares of the firm's stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares of the company's stock, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,723 shares of company stock worth $26,241,747 in the last three months. Insiders own 0.80% of the company's stock.

Intuitive Surgical Trading Down 2.1 %

Intuitive Surgical stock traded down $11.55 during mid-day trading on Monday, hitting $538.86. The stock had a trading volume of 1,426,615 shares, compared to its average volume of 1,253,917. The stock has a 50-day simple moving average of $516.21 and a two-hundred day simple moving average of $474.66. The stock has a market capitalization of $191.93 billion, a PE ratio of 88.49, a P/E/G ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a 12 month low of $307.72 and a 12 month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.